Cargando…

Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency

Detalles Bibliográficos
Autores principales:	Squire, Jacqueline, Joshi, Avni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2021
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132495/ https://www.ncbi.nlm.nih.gov/pubmed/34022388 http://dx.doi.org/10.1016/j.anai.2021.05.015

Ejemplares similares

Predictors of seroconversion after coronavirus disease 2019 vaccination
por: Chiarella, Sergio E., et al.
Publicado: (2022)

Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies
por: Squire, Jacqueline D., et al.
Publicado: (2021)

Risk of allergic reaction in patients with atopic disease and recent coronavirus disease 2019 vaccination
por: Dages, Kelley N., et al.
Publicado: (2021)

Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: Early report
por: Pitlick, Mitchell M., et al.
Publicado: (2021)

Predictors Of Seroconversion Following COVID-19 Vaccination
por: Chiarella, Sergio, et al.
Publicado: (2022)

Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants
por: Alfano, Gaetano, et al.
Publicado: (2021)

SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity
por: Anft, Moritz, et al.
Publicado: (2023)

Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis
por: Liebers, Nora, et al.
Publicado: (2022)

Seroconversion after Inactive SARS-CoV-2 Vaccination and Obesity: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Coronavirus disease 2019 vaccines in pregnancy
por: Al-Lami, Rasha A.
Publicado: (2021)

Seroconversion after SARS-CoV-2 mRNA booster vaccine in cancer patients
por: Patelli, Giorgio, et al.
Publicado: (2022)

Coronavirus disease 2019 vaccine skin testing and graded challenges in vaccine-hesitant patients
por: Heffes-Doon, Ari, et al.
Publicado: (2023)

Polyethylene glycol and polysorbate testing in 12 patients before or after coronavirus disease 2019 vaccine administration
por: Carpenter, Taya, et al.
Publicado: (2022)

Reply: Coronavirus disease 2019 vaccines in pregnancy
por: Craig, Amanda M., et al.
Publicado: (2021)

Disproportionality analysis of anaphylactic reactions after vaccination with messenger RNA coronavirus disease 2019 vaccines in the United States
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

Seroconversion after influenza vaccination in patients with lung cancer
por: Anderson, H, et al.
Publicado: (1999)

Seroconversion of severe acute respiratory syndrome coronavirus 2–infected patients on immunosuppression: A retrospective analysis
por: Smith, Jeffrey S., et al.
Publicado: (2021)

A coronavirus disease 2019–vaccinated patient with phosphoinositide 3-kinase disease with mild illness after severe acute respiratory syndrome coronavirus 2 infection
por: Sarkaria, Sandeep, et al.
Publicado: (2022)

Contraception, vaccination and coronavirus disease 2019 pandemic: correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing
por: Kohli-Pamnani, Anita, et al.
Publicado: (2022)

Graded coronavirus disease 2019 vaccine administration: A safe alternative to vaccine avoidance
por: Pitlick, Mitchell M., et al.
Publicado: (2022)

Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Immune response after vaccination using inactivated vaccine for coronavirus disease 2019
por: Sun, Ya, et al.
Publicado: (2023)

Coronavirus disease 2019 vaccination and live birth outcome after fresh embryo transfer
por: Huang, Jialyu, et al.
Publicado: (2022)

Prolonged virus shedding even after seroconversion in a patient with COVID-19
por: Liu, Wang-Da, et al.
Publicado: (2020)

Delayed hypersensitivity to the Comirnaty coronavirus disease 2019 vaccine presenting with pneumonitis and rash
por: Stoyanov, Alex, et al.
Publicado: (2022)

Can the coronavirus disease‐2019 vaccine induce an asthma attack?
por: Kawasaki, Takaaki, et al.
Publicado: (2021)

Venous thromboembolism in hospitalized coronavirus disease 2019 patients stratified by vaccination status
por: Bozzani, Antonio, et al.
Publicado: (2023)

Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?
por: Bril, Fernando, et al.
Publicado: (2021)

Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies
por: Mohan, Meera, et al.
Publicado: (2022)

Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies
por: Wong, Lydia Su Yin, et al.
Publicado: (2023)

Split dosing of coronavirus disease 2019 vaccines provides noninferior antibody responsiveness to conventional vaccine dosing
por: Musa, Amal, et al.
Publicado: (2022)

Outcomes of allergic-type reactions after messenger RNA coronavirus disease 2019 vaccination at 3 military medical centers
por: St. Clair, Benjamin D., et al.
Publicado: (2022)

Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose
por: Van Meerbeke, Sara W., et al.
Publicado: (2022)

Hantavirus seroconversion of wild-caught Peromyscus during quarantine.
por: Camaioni, M, et al.
Publicado: (2001)

EP1270: SEROCONVERSION IN INFLAMMATORY BOWEL DISEASE PATIENTS AFTER COVID-19 VACCINATION
por: Horvath, Miklos, et al.
Publicado: (2022)

Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis
por: Pienkowski, Marek M., et al.
Publicado: (2022)

From coronavirus disease 2019 to long coronavirus disease 2019 in vascular pathology
por: Farinetti, Alberto, et al.
Publicado: (2022)

Influence of vaccination and immunosuppressive treatments on the coronavirus disease 2019 outcomes in patients with systemic autoimmune diseases
por: Álvarez-Troncoso, Jorge, et al.
Publicado: (2023)

A case of coronavirus disease 2019 messenger RNA vaccine tolerance and immune response despite presence of anti-polyethylene glycol antibodies
por: Corey, Kristen B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r9pqsl9ps08j3s25q11860eq98